Palladium-103 Radiation Effective for Small Choroidal MelanomaPalladium-103 Radiation Effective for Small Choroidal Melanoma
Palladium-103 plaque radiation therapy was effective for treating small choroidal melanomas in a retrospective study. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 25, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Occupational Exposure and Risk of Pediatric RetinoblastomaOccupational Exposure and Risk of Pediatric Retinoblastoma
What does the latest science tell us about the possible connection between mens' occupational exposures and the potential development of sporadic bilateral retinoblastoma in their children? Occupational and Environmental Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 12, 2013 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
In Metastatic Uveal Melanoma, New Drug Improves Progression-Free Survival, Shrinks Tumors
The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented at the 49th annual meeting of the American Society of Clinical Oncology (ASCO). The findings are potentially practice-changing for a historically "untreatable disease... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 4, 2013 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news
First Drug To Help Melanoma Of The Eye
AstraZeneca's experimental drug, selumetinib, is the first targeted medication to show a significant clinical benefit for patients with melanoma of the eye (metastatic uveal melanoma), researchers from the Memorial Sloan-Kettering Cancer Center explained at the 49th annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago, Illinois. The scientists say that their findings will probably change clinical practice for patients with metastatic uveal melanoma, which to date has been an "untreatable disease"... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 2, 2013 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news
ASCO: Rare Eye Cancer Yields to Targeted Drug
CHICAGO (MedPage Today) -- The novel kinase inhibitor selumetinib may be the first treatment to shrink advanced uveal melanoma, based on phase II trial results. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 2, 2013 Category: Hematology Source Type: news
Breakthrough in Rare Cancer: First Drug Works Uveal MelanomaBreakthrough in Rare Cancer: First Drug Works Uveal Melanoma
For the first time, a systemic therapy has shown clinical activity in a rare eye cancer, metastatic uveal melanoma, for which there is no standard treatment. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Breakthrough in Rare Eye Cancer: First Drug That WorksBreakthrough in Rare Eye Cancer: First Drug That Works
For the first time, a systemic therapy has shown clinical activity in a rare eye cancer, metastatic uveal melanoma, for which there is no standard treatment. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Drug Is a First to Help Patients with Melanoma of the Eye
In his first few weeks as head of the melanoma group at Memorial Sloan-Kettering Cancer Center seven years ago, a young man walked into Dr. Gary Schwartz's office with a rare form of the skin cancer that affects the eye.Source: Reuters Health
Related MedlinePlus Pages: Eye Cancer, Melanoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 1, 2013 Category: Consumer Health News Source Type: news
New drug improves progression-free survival, shrinks tumors in rare cancer for first time
(Memorial Sloan-Kettering Cancer Center) The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2013 Category: Global & Universal Source Type: news
Link Suggested Between Tumor Suppressors And Starvation Survival
A particular tumor suppressor gene* that fights cancer cells does more than clamp down on unabated cell division -- the hallmark of the disease -- it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study. CU-Boulder Professor Min Han said the research team was interested in how a common tumor suppressor gene known as Retinoblastoma 1, or Rb, behaved under conditions of starvation... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 14, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
FDA advisers recommend against Delcath's cancer therapy
(Reuters) - A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer therapy for a rare form of eye cancer that spreads to the liver, saying it was too risky. (Source: Reuters: Health)
Source: Reuters: Health - May 2, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
